Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Genmab A (GMAB) Current Leases (2023 - 2025)

Historic Current Leases for Genmab A (GMAB) over the last 3 years, with Q4 2025 value amounting to $18.0 million.

  • Genmab A's Current Leases rose 3846.15% to $18.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $18.0 million, marking a year-over-year increase of 3846.15%. This contributed to the annual value of $18.0 million for FY2025, which is 3846.15% up from last year.
  • According to the latest figures from Q4 2025, Genmab A's Current Leases is $18.0 million, which was up 3846.15% from $126.0 million recorded in Q3 2025.
  • Genmab A's Current Leases' 5-year high stood at $132.0 million during Q2 2025, with a 5-year trough of $13.0 million in Q4 2023.
  • For the 3-year period, Genmab A's Current Leases averaged around $71.8 million, with its median value being $72.0 million (2025).
  • Per our database at Business Quant, Genmab A's Current Leases changed by 0.0% in 2024 and then surged by 3846.15% in 2025.
  • Genmab A's Current Leases (Quarter) stood at $13.0 million in 2023, then changed by 0.0% to $13.0 million in 2024, then soared by 38.46% to $18.0 million in 2025.
  • Its Current Leases was $18.0 million in Q4 2025, compared to $126.0 million in Q3 2025 and $132.0 million in Q2 2025.